Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Sep 24 | CLDI Calidi Biotherapeutics | NQSO Common stock | Grant | Acquire A | No | No | 1.09 | 20,217 | 22.04 k | 20,217 |
28 Jun 24 | CLDI Calidi Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 79,687 | 0.00 | 1,071,781 |
5 Jun 24 | FGEN FibroGen | Stock Option Common Stock | Grant | Acquire A | No | No | 1.21 | 70,000 | 84.70 k | 70,000 |
3 Jun 24 | CLDI Calidi Biotherapeutics | Option exercise | Acquire M | Yes | No | 0.2 | 375,000 | 75.00 k | 963,887 | |
3 Jun 24 | CLDI Calidi Biotherapeutics | Option exercise | Acquire M | Yes | No | 0.2 | 173,000 | 34.60 k | 588,887 | |
3 Jun 24 | CLDI Calidi Biotherapeutics | Common Stock | Grant | Acquire A | Yes | No | 0.3 | 548,000 | 164.40 k | 548,000 |
3 Jun 24 | CLDI Calidi Biotherapeutics | Common Stock | Option exercise | Acquire M | Yes | No | 0.2 | 375,000 | 75.00 k | 375,000 |
3 Jun 24 | CLDI Calidi Biotherapeutics | Series C Unit | Option exercise | Dispose M | Yes | No | 0.2 | 375,000 | 75.00 k | 0 |
3 Jun 24 | CLDI Calidi Biotherapeutics | Common Stock | Option exercise | Acquire M | Yes | No | 0.2 | 173,000 | 34.60 k | 173,000 |
3 Jun 24 | CLDI Calidi Biotherapeutics | Series B Unit | Option exercise | Dispose M | Yes | No | 0.2 | 173,000 | 34.60 k | 202,000 |